SUBSCRIBE
SUBSCRIBE
News   Business

Stemgent Raises $14 Million

March 10, 2009 | 
1 min read

Stemgent Inc., a Cambridge, Mass.-based provider of stem cell technologies and research tools, has raised $14 million in Series A-1 funding, according to a regulatory filing. Backers include HealthCare Ventures and Morgenthaler Ventures.

Startups
MORE ON THIS TOPIC
Aerial view of Gyles Quay, Dundalk, Louth, Ireland
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
January 6, 2025
 · 
1 min read
 · 
Annalee Armstrong
An aerial view rendering of The Foundry
Partnered
All About Speed: Lilly Drives Innovation With New Facility to Help Bring Medicines to Market
January 6, 2025
 · 
5 min read
 · 
BioSpace Insights
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
Mergers & acquisitions
Higher Biopharma M&A Activity ‘Almost Inevitable’ in 2025, With Viking as Top Candidate: Analysts
January 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Symbol of money dollar from colored pills and capsules on green background. Expensive medicine and medical insurance
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
January 6, 2025
 · 
1 min read
 · 
Annalee Armstrong